Measuring HPV vaccination coverage in Australia: comparing two alternative population‐based denominators

by Bianca Barbaro, Julia M.L. Brotherton
Published 2015-08-01

Assessing HPV vaccine coverage in Australia by geography and socioeconomic status: are we protecting those most at risk?

by Bianca Barbaro, Julia M.L. Brotherton
Published 2014-10-01

Hepatitis B Vaccines and HPV Vaccines Have Been Hailed as Major Public Health Achievements in Preventing Cancer--Could a Schistosomiasis Vaccine be the Third?

by Michael H Hsieh, Julia M L Brotherton, Afzal A Siddiqui
Published 2015-05-01

Understanding the participation of breast screening among women born in predominantly Muslim countries living in Victoria, Australia from record-linkage data.

by Tahira Yeasmeen, Margaret Kelaher, Julia M L Brotherton, Michael J Malloy
Published 2020-01-01

Monitoring the impact of HPV vaccine in males—Considerations and challenges

by Julia M.L. Brotherton, Anna R. Giuliano, Lauri E. Markowitz, Eileen F. Dunne, Gina S. Ogilvie
Published 2016-12-01

Effectiveness of less than three doses of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia when administered using a standard dose spacing sched...

by Julia M.L. Brotherton, Michael Malloy, Alison C. Budd, Marion Saville, Kelly T. Drennan, Dorota M. Gertig
Published 2015-12-01

Getting the timing right: Women’s views on the best time to announce changes to cancer screening policy recommendations

by Rachael H. Dodd, Brooke Nickel, Megan A. Smith, Julia M.L. Brotherton, Kirsten J. McCaffery
Published 2020-12-01

Risk of cervical pre-cancer and cancer in women with multiple sclerosis exposed to high efficacy disease modifying therapies

by Francesca Bridge, Francesca Bridge, Julia M. L. Brotherton, Julia M. L. Brotherton, Yi Foong, Yi Foong, Yi Foong, Helmut Butzkueven, Helmut Butzkueven, Vilija G. Jokubaitis, Vilija G. Jokubaitis, Anneke Van der Walt, Anneke Van der Walt
Published 2023-02-01

Implementation of Australia's renewed cervical screening program: Preparedness of general practitioners and nurses.

by Farhana Sultana, Lara Roeske, Michael J Malloy, Tracey L McDermott, Marion Saville, Julia M L Brotherton
Published 2020-01-01

Study protocol: Yarning about HPV Vaccination: a qualitative study of factors influencing HPV vaccination among Aboriginal and Torres Strait Islander adolescents in Australia

by Allison Tong, Julia M L Brotherton, Gail Garvey, Joan Cunningham, Lisa J Whop, Kate Anderson, Tamara L Butler
Published 2021-08-01

The acceptability of, and informational needs related to, self‐collection cervical screening among women of Indian descent living in Victoria, Australia: A qualitative study

by Ana Machado Colling, Nicola S. Creagh, Neha Gogia, Kerryann Wyatt, Claire Zammit, Julia M. L. Brotherton, Claire E. Nightingale
Published 2024-02-01

Human papillomavirus and head and neck cancers: emerging trends and improving survival

by Julia M.L. Brotherton, Alicia N. Stein, E. Lynne Conway, David G. Regan, Andrew Grulich, Matthew Law, Jane S. Hocking
Published 2012-04-01

Self-Collection for Cervical Screening Programs: From Research to Reality

by David Hawkes, Marco H. T. Keung, Yanping Huang, Tracey L. McDermott, Joanne Romano, Marion Saville, Julia M. L. Brotherton
Published 2020-04-01

Successful Kidney Transplantation in a Recipient Coinfected with Hepatitis C Genotype 2 and HIV from a Donor Infected with Hepatitis C Genotype 1 in the Direct-Acting Antiviral Era

by Dimitrios Farmakiotis, Zoe Weiss, Amy L. Brotherton, Paul Morrissey, Reginald Gohh, Kendra Vieira, Lynn E. Taylor, Joseph M. Garland
Published 2020-01-01

National genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: a systematic review and meta-analysis protocol

by Matthew Palmer, Kota Katanoda, Eiko Saito, Cecilia Acuti Martellucci, Shiori Ostuki, Shuhei Nomura, Erika Ota, Julia M. L. Brotherton, Jane Hocking
Published 2021-05-01

HPV vaccination of immunocompromised hosts

by S.M. Garland, J.M.L. Brotherton, A.B. Moscicki, A.M. Kaufmann, M. Stanley, N. Bhatla, R. Sankaranarayanan, S. de Sanjosé, J.M. Palefsky
Published 2017-12-01

Health care provider perspectives on cervical screening for Aboriginal and Torres Strait Islander women: a qualitative study

by Rachael Jaenke, Tamara L. Butler, John Condon, Gail Garvey, Julia M.L. Brotherton, Joan Cunningham, Kate Anderson, Allison Tong, Suzanne P. Moore, Lisa J. Whop
Published 2021-04-01

Implementation of Australia’s primary human papillomavirus (HPV) cervical screening program: The STakeholders Opinions of Renewal Implementation and Experiences Study

by Julia M.L. Brotherton, Tracey McDermott, Megan A. Smith, Dorothy A. Machalek, Hannah Shilling, Khic-Houy Prang, Chloe Jennett, Claire Nightingale, Claire Zammit, Amy Pagotto, Nicole M. Rankin, Margaret Kelaher
Published 2023-06-01

Increased risk of cervical dysplasia in females with autoimmune conditions-Results from an Australia database linkage study.

by Emma Foster, Michael J Malloy, Vilija G Jokubaitis, C David H Wrede, Helmut Butzkueven, Joe Sasadeusz, Sharon Van Doornum, Finlay Macrae, Gary Unglik, Julia M L Brotherton, Anneke van der Walt
Published 2020-01-01

Protocol for the formative phase of a trial (SHE-CAN) to test co-designed implementation strategies for HPV-based cervical screening among vulnerable women in two diverse settings...

by Anu Mary Oommen, Partha Basu, Anne George Cherian, Eric Zomawia, Ravikumar Manoharan, Ruby Angeline Pricilla, Vidhya Viswanathan, Brian Oldenburg, Sujha Subramanian, David Hawkes, Marion Saville, Julia M. L. Brotherton, on behalf of the SHE-CAN collaborators
Published 2023-06-01